Cutaneous basal cell carcinomas
- 15 July 2001
- Vol. 92 (2), 354-358
- https://doi.org/10.1002/1097-0142(20010715)92:2<354::aid-cncr1330>3.0.co;2-f
Abstract
BACKGROUND Patients with basal cell carcinoma (BCC) demonstrate marked variation in clinical phenotype, suggesting the presence of distinct subgroups. Patients with truncal lesions comprise an interesting subgroup, because, although the pathogenesis of these tumors is unclear, there is evidence to suggest that their development is mediated by different mechanisms than the mechanisms that mediate the development of BCC on other sites. The authors now speculate that some patients inherit a predisposition to truncal BCC and develop disproportionately more BCC on this site than other patients. METHODS The authors studied 100 patients who, at the time of initial presentation, had a truncal BCC lesion and 493 patients who had a lesion on the head and neck. The 493 patients with head and neck lesions included 36 patients who subsequently developed a truncal BCC and 457 patients who do not. RESULTS Initial presentation with a truncal tumor was associated with significantly more subsequent BCC lesions on this site compared with patients who presented initially with a head and neck lesion. The mean truncal tumor accrual after initial presentation in patients who presented with an initial truncal BCC lesion was 0.13 BCC lesions per year compared with 0.03 BCC lesions per year in patients who presented with an initial head and neck lesion (P < 0.001). Patients with truncal lesions were significantly younger at the time of initial presentation and developed more clusters of BCC lesions (2–10 new tumors at any presentation) compared with patients who did not develop tumors on the trunk. CONCLUSIONS These data suggest that the development of a truncal BCC is not random but, rather, is associated with a predisposition. In contrast, the accrual of nontruncal BCC lesions was similar in patients with and without initial truncal lesions, suggesting that different mechanisms determine the development of truncal BCC and nontruncal BCC. Cancer 2001;92:354–8. © 2001 American Cancer Society.Keywords
This publication has 10 references indexed in Scilit:
- Basal cell carcinomaCancer, 2000
- Differences in Age, Site Distribution, and Sex Between Nodular and Superficial Basal Cell Carcinomas Indicate Different Types of TumorsJournal of Investigative Dermatology, 1998
- Truncal site and detoxifying enzyme polymorphisms significantly reduce time to presentation of further primary cutaneous basal cell carcinomaCarcinogenesis: Integrative Cancer Research, 1997
- Risk Factors for Basal Cell Carcinoma in the UK: Case-Control Study in 806 PatientsJournal of the Royal Society of Medicine, 1997
- Differences in Age and Body Site Distribution of the Histological Subtypes of Basal Cell CarcinomaArchives of Dermatology, 1997
- Truncal Tumor Site Is Associated with high Risk of Multiple Basal Cell Carcinoma and Is Influenced by Glutathione S-Transferase, GSTT1, and Cytochrome P450, CYP1A1 Genotypes, and Their InteractionJournal of Investigative Dermatology, 1997
- The role of the human homologue of Drosophila patched in sporadic basal cell carcinomasNature Genetics, 1996
- Glutathione S-transferase M1 and T1 polymorphisms: susceptibility to colon cancer and age of onsetCarcinogenesis: Integrative Cancer Research, 1995
- Sun exposure and non-melanocytic skin cancerCancer Causes & Control, 1994
- Glutathione S-transferase GSTM1 phenotypes and protection against cutaneous tumoursThe Lancet, 1994